PATIENT INFORMATION LEAFLET

Similar documents
PATIENT INFORMATION LEAFLET. Calcichew* 500 mg Chewable Tablets calcium carbonate

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user. Calcichew-D 3 Melon 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 )

Package leaflet: Information for the use. Calcichew-D3 Citron 500 mg/400 IU chewable tablets calcium / cholecalciferol (vitamin D3)

Package leaflet: Information for the user. Calcichew-D 3 Citron 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 )

Package leaflet: Information for the user

Package leaflet: Information for the user. Calciflex-D 3 Citron 500 mg/400 IU film-coated tablets calcium/cholecalciferol (vitamin D 3 )

Package leaflet: Information for the user. Calcichew-D 3 Forte Double Strength 1000 mg/800 IU chewable tablets calcium/colecalciferol (vitamin D 3 )

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)

SUMMARY OF THE PRODUCT CHARACTERISTICS

Package leaflet: Information for the user. Calcichew-D 3 Citron 1000 mg/800 IU chewable tablets calcium/cholecalciferol (vitamin D 3)

Package leaflet: Information for the user. Recikalc-D forte 500 mg/800 IU chewable tablets. Calcium/cholecalciferol (Vitamin D3)

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

Excipient(s) with known effect: One tablet contains 1 mg aspartame (E951), 390 mg sorbitol (E420) and 0.7 mg sucrose

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Fultium can also be used as an adjunct to specific bone loss medication

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

1. NAME OF THE MEDICINAL PRODUCT. Calciflex-D 3 Citron 500 mg/400 IU film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Package leaflet: Information for the user Phosex 1000 mg Tablets Calcium acetate

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

Package leaflet: Information for the patient

SUMMARY OF PRODUCT CHARACTERISTICS. One chewable tablet contains 1250 mg calcium carbonate (equivalent to 500 mg calcium).

Package leaflet: Information for the user. Kalcipos-D forte 500 mg/800 IU film-coated tablets. Calcium/cholecalciferol (Vitamin D3)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 5 mg film-coated tablets risedronate sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 35 mg film-coated tablets risedronate sodium

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

Package leaflet: Information for the patient. Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets.

THORENS I.U. /ml oral drops, solution Cholecalciferol (vitamin D 3 )

SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

Package leaflet: Information for user

Package leaflet: Information for the patient

Dosage in renal impairment Kalcipos-D chewable tablets should not be used in patients with severe renal impairment.

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

2. What you need to know before you take DDAVP/Desmopressin Tablets

Package leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline

Package leaflet: Information for the user. Ezetimibe STADA 10 mg, tabletten. Ezetimibe

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package leaflet: Information for the patient

Package leaflet: Information for the user. Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium)

Package leaflet: Information for the patient. Megalac Almasilate 1 g/10 ml suspension. Active substance: almasilate

SUMMARY OF THE PRODUCT CHARACTERISTICS

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

SUMMARY OF THE PRODUCT CHARACTERISTICS

Sibelium 5 mg Tablets flunarizine

Package leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides

Package Leaflet: Information for the Patient. FOSRENOL 750 mg oral powder. FOSRENOL 1000 mg oral powder. lanthanum

Package leaflet: Information for the user

Package Leaflet: Information for the patient. FERROUS SULFATE TABLETS 200 mg Ferrous Sulfate

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

PACKAGE LEAFLET: INFORMATION FOR THE USER. altavitad3 25,000 IU oral solution colecalciferol

Package leaflet: Information for the user. Fluvastatin

Package leaflet: Information for the patient. Ezetimibe 10 mg tablets ezetimibe

Article 30 Referral for Calcitugg (and associated names) Chewable tablets (Calcium carbonate)

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

Irbenida H 150mg/12,5mg film-coated tablets

Package leaflet: Information for the user. Levonorgestrel 1.5 mg Tablet. levonorgestrel

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. Anastrozole 1 mg film-coated tablets

Package leaflet: Information for the user

Package leaflet: Information for the user

Summary of Product Characteristics

PACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil

PACKAGE LEAFLET: INFORMATION FOR THE USER. Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride)

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

Bonefos 400 mg capsules sodium clodronate

1. What Miacalcic is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Package Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 30 mg film-coated tablets risedronate sodium

Package leaflet: Information for the user. Nocdurna 25 microgram oral lyophilisate Nocdurna 50 microgram oral lyophilisate.

If you have any questions about how Letrozole Tablets works or why this medicine has been prescribed for you, ask your doctor.

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER

Produktinformationen för Calcichew-D3 Citron, 1000 mg/800 IE tuggtablett, MTnr 26065, gäller vid det tillfälle då läkemedlet godkändes.

Package leaflet: Information for the user. ELEVIT PRONATAL film-coated tablets 12 vitamins and 7 minerals and trace elements

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

Imodium 1 mg/5 ml oral solution

Package leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets

Package Leaflet: Information for the Patient. FOSRENOL 750 mg chewable tablets. FOSRENOL 1000 mg chewable tablets. lanthanum

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the patient

Package leaflet: Information for the patient. [To be completed nationally] 10 mg film-coated tablets Ebastine

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

Transcription:

PATIENT INFORMATION LEAFLET CALCICHEW*-D 3 FORTE 500 mg/400 IU CHEWABLE TABLETS calcium/colecalciferol Read all of this leaflet carefully because it contains important information for you. - Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - You must talk to a doctor if you do not feel better or if you feel worse after two weeks. - If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. In this leaflet: 1. What Calcichew-D 3 Forte is and what it is used for 2. What you need to know before you take Calcichew-D 3 Forte 3. How to take Calcichew-D 3 Forte 4. Possible side effects 5. How to store Calcichew-D 3 Forte 6. Contents of the pack and other information 1. WHAT CALCICHEW- D 3 FORTE IS AND WHAT IT IS USED FOR Calcichew-D 3 Forte Chewable Tablets are lemon flavoured chewable tablets containing calcium and vitamin D 3 which are both important substances in bone formation. Both are found in the diet and vitamin D is also produced in the skin after exposure to the sun. Calcichew-D 3 Forte is used to treat and prevent vitamin D/calcium deficiency, which may occur when your diet or lifestyle does not provide enough, or when body requirements are increased. This medicine may also be prescribed or recommended for certain bone conditions, for example osteoporosis, or during pregnancy. 2. BEFORE YOU TAKE CALCICHEW- D 3 FORTE Do not take Calcichew- D 3 Forte Chewable Tablets if you: are allergic to calcium, vitamin D, or any of the other ingredients of this medicine (listed in section 6) have severe kidney problems have a condition that causes excessive amounts of calcium in your blood or urine (hypercalcaemia or hypercalciuria) e.g. o renal (kidney failure) o cancer that has affected your bones have excessive amounts of vitamin D in your blood have kidney stones. Warnings and precautions Talk to your doctor or pharmacist before taking Calcichew- D 3 Forte: if you have osteoporosis (brittle bones) and are also unable to move around

if you are on long term treatment, especially if you are taking medicines for a heart disorder (cardiac glycosides), or diuretics (used in the treatment of high blood pressure or oedema) if you have signs of impaired kidney function or a high tendency to kidney stone (calculus) formation if you have cancer or any other condtions that may have affected your bones if you have sarcoidosis (an immune system disorder which may cause increased levels of vitamin D in the body). If you have any of the following conditions your serum calcium or phosphate levels, or urinary calcium excretion must be monitored. Calcichew should be taken under close medical supervision. sarcoidosis (an immune system disorder which may affect your liver, lungs, skin or lymph nodes) kidney problems you are on long-term treatment with Calcichew you are already taking additional doses of calcium or vitamin D. If you have increased calcium levels in the blood or develop signs of kidney problems, the dose of Calcichew-D 3 Forte should be reduced or the treatment discontinued. Other medicines and Calcichew- D 3 Forte Please inform your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. In particular, the following medicines may interact with Calcichew-D 3 Forte chewable tablets: thiazide diuretics (water tablets); your serum calcium levels should be monitored regularly. cardiac glycosides (heart medicines); you should be monitored by electrocardiogram (ECG) and your serum calcium levels measured. tetracycline antibiotics; these should be taken at least two hours before, or four to six hours afterwards. Calcium carbonate may interfere with the absorption of tetracycline preparations if taken at the same time. levothyroxine (hormone used to treat thyroid deficiency); these should be taken at least four hours before or after taking Calcichew- D 3 Forte quinolone antibiotics (ciprofloxacin, lomefloxacin, norfloxacin, sparfloxacin): the effect of these medicines may be reduced if taken at the same time as calcium. Take quinolone antibiotics two hours before or six hours after taking Calcichew- D 3 Forte. bisphosphonates; should be taken at least one hour before Calcichew-D 3 Forte Calcium salts may decrease the absorption of iron, zinc and strontium ranelate. Consequently iron, zinc or strontium ranelate preparations should be taken at least two hours before or after Calcichew-D 3 Forte Orlistat (used to treat obesity) may disturb the absorption of fat-soluble vitamins, e.g. vitamin D3. If you are taking any of the above-mentioned medicines, your doctor will give you further instructions. Taking Calcichew-D 3 Forte with food and drink Calcichew-D 3 Forte can be taken with or without food and drink.

Pregnancy and breastfeeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice if you are pregnant or breast-feeding before taking Calcichew-D 3 Forte. If you are pregnant, you may use Calcichew-D 3 Forte in case of a calcium and vitamin D deficiency. During pregnancy you should not take more than 2500 mg calcium and 4000 IU vitamin D per day, as overdoses may harm the unborn child. Calcichew-D 3 Forte can be used during breast-feeding. Calcium and vitamin D 3 pass into breast milk. This should be considered when giving additional vitamin D to the child. Driving and using machines Calcichew- D 3 Forte has no known influence on the ability to drive or use machines. Calcichew- D 3 Forte contains isomalt and sucrose. Calcichew-D 3 Forte contains isomalt (E953) and sucrose (E420): if you have been told by your doctor that you have an intolerance to some sugars, talk to your doctor before taking this medicine. May be harmful to teeth. 3. HOW TO TAKE CALCICHEW- D 3 FORTE Always take Calcichew- D 3 Forte Tablets exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Dosage The recommended dose is two tablets a day, preferably one tablet in the morning and one tablet in the evening. The tablet may be chewed or sucked. Children Calcichew-D 3 Forte chewable tablets are not recommended for use in children If you take more than you should If you have taken more Calcichew- D 3 Forte than you should, talk to your doctor or pharmacist immediately. If you forget to take Calcichew- D 3 Forte Chewable Tablets Do not take a double dose to make up for a forgotten tablet. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, this medicine can cause side effects, although not everybody gets them. Stop taking your medicine and see a doctor immediately if you experience: Frequent urge to urinate Headache Loss of appetite, nausea or vomiting Unusual tiredness or weakness, along with elevated levels of calcium in the blood and kidney impairment

Side effects may include: Uncommon side effects (may affect less than 1 in 100 people): excessive amounts of calcium in your blood (hypercalcaemia) or in your urine (hypercalcuria) may occur with large doses Rare side effects (may affect less than 1 in 1,000 people): nausea stomach ache constipation heartburn (dyspepsia) diarrhoea wind (flatulence) rash hives itching Very rare side effects (may affect less than 1 in 10,000 people): Milk alkali syndrome (also called Burnett s Syndrome and usually only seen when excessive amounts of calcium have been ingested), symptoms are frequent urge to urinate, headache, loss of appetite, nausea or vomiting, unusual tiredness or weakness, along with elevated levels of calcium in the blood and kidney impairment. Side effects with frequency not known (cannot be estimated from the available data): Hypersensitivity reactions such as swelling of the face, tongue, lips (angioedema) or swelling of the throat (laryngeal oedema). If you have impaired renal function, you may be at risk of increased amounts of phosphate in the blood, renal stone formation and increased amounts of calcium in the kidneys. Reporting of side effects If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www. yellowcard.mhra.gov.uk/. By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE CALCICHEW-D 3 FORTE Keep out of the sight and reach of children. Store in the original package. Keep container tightly closed to protect from moisture. Do not store above 30 C Do not use Calcichew- D 3 Forte Tablets after the expiry date which is stated on the label after EXP. The expiry date refers to the last date of that month. If the tablets have changed shape or colour do not use. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment. 6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Calcichew-D 3 Forte Chewable Tablets contain The active ingredients in each tablet are: 1250mg calcium carbonate (equivalent to 500mg calcium) 400IU colecalciferol (equivalent to 10 micrograms vitamin D 3 ) The other ingredients are: xylitol (E967), povidone, isomalt (E953), fatty acid mono- and diglycerides, magnesium stearate, lemon flavour, sucralose (E955), sucrose, tocopherol, modified maize starch, medium-chain triglycerides, sodium ascorbate and anhydrous colloidal silica (see also end of Section 2 Calcichew-D 3 Forte contains isomalt and sucrose ). What Calcichew-D 3 Forte look like and contents of the pack The tablets are round, white, uncoated, convex and lemon flavoured; they may have small specks. The tablets are packed in white, plastic bottles of 60 and 100 tablets. Not all pack sizes may be marketed. Marketing Authorisation Holder Takeda UK Ltd., Building 3, Glory Park, Glory Park Avenue, Wooburn Green, BUCKS, HP10 0DF, United Kingdom Manufacturer Takeda AS, Drammensveien 852, N-1385 Asker, Norway. This leaflet was last revised in June 2017. Additional Information Calcichew-D 3 Forte are a combination of calcium and vitamin D designed to keep bones healthy. Calcium is an essential component of bones while vitamin D plays an important role in the absorption of calcium from food. Requirements for calcium increase with age and, although many people obtain enough calcium from their diet, some people may require a supplement in order that their body has all the calcium it needs to maintain healthy bones. Vitamin D is produced largely from the action of sunlight. Certain foodstuffs do contain vitamin D in reasonable amounts but it is not always possible to obtain all the vitamin D you need from your diet. People who do not get out and about, for instance those who are housebound or people living in nursing and residential homes, may not receive all the vitamin D they need. People with diets and lifestyles that mean they will obtain less than the recommended intake of calcium and vitamin D are at risk of weakened bones. Prolonged lack of adequate calcium and vitamin D intake can lead to the development of osteoporosis, a condition where bones become weak to a level that minimal trauma (for example, a fall) can result in a fracture, most typically at the hip, spine or wrist. Calcichew-D 3 Forte have been designed to give people whose intakes of calcium and vitamin D are low a boost to the recommended amounts. Maintaining healthy bones and helping to avoid osteoporosis is an important issue for many people. There are many ways that people can help themselves: regular exercise, a balanced diet with an adequate intake of calcium and vitamin D and, for some people, advice on how to prevent falls which may lead to fracture.

The National Osteoporosis Society (NOS) is a national charity dedicated to improving the diagnosis, prevention and treatment of osteoporosis. The NOS offers support to people with osteoporosis and raises awareness of the importance of healthy bones. If you are concerned about osteoporosis, please contact the National Osteoporosis Society, Camerton, Bath BA2 0PJ. Tel: 01761 471 771, Fax: 01761 471 104 or email: info@nos.org.uk. *Registered Trademark